Products
Online Inquiry
Caffeic acid phenethyl ester
Cat. No.:
OB0225WX-2684
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Caffeic acid phenethyl ester is a potent and specific antagonist of NF-kappaB activation that also possesses intrinsic antioxidant, anti-inflammatory, and immunomodulatory properties.
Synonym:
CAPE; Phenylethyl Caffeate; 104594-70-9; Phenethyl caffeate; Phenethyl 3-(3,4-dihydroxyphenyl)acrylate; Capeee; Phenylethyl caffeate; Caffeic acid phenylethyl ester; 2-phenylethyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, 2-phenylethyl ester; 2-Phenylethyl (2e)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate; 2-phenylethyl caffeate; (E)-phenethyl 3-(3,4-dihydroxyphenyl)acrylate; MFCD00866470; Caffeic acid-phenethyl ester; Phenethyl (E)-caffeate; Phenethyl 3,4-dihydroxycinnamate; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid 2-phenylethyl ester; Caffeic acid ester; QAP; 2-phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate; Caffeic acidphenethylester; Caffeic acid phenethylester; Caffeic-acid-phenethyl-ester; Caffeic acid phenylethylester
CAS No.:
104594-70-9
Compound CID:
5281787
Formula:
C17H16O4
Formula Weight:
284.31
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Caffeic acid phenethyl ester is used in biochemical and oncology research as a bioactive derivative of propolis to examine the selective inhibition of NF-kappaB activation and its potent antioxidant and pro-apoptotic activities.
Library Information
Target:
NF-κB
Receptor:
NF-κB
Pathways:
NF-κB
Plate Number:
L6700-08
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
57 mg/mL; 200.49 mM
Ethanol Max Solubility:
57 mg/mL
ALogP:
3.573
HBA_Count:
2
HBD_Count:
2
Rotatable Bond:
6
